McDevitt M A, Gilmartin G M, Reeves W H, Nevins J R
Howard Hughes Medical Institute, Laboratory of Molecular Cell Biology, Rockefeller University, New York, New York 10021.
Genes Dev. 1988 May;2(5):588-97. doi: 10.1101/gad.2.5.588.
Polyadenylation of pre-mRNAs in the nucleus involves a specific endonucleolytic cleavage, followed by the addition of approximately 200 adenylic acid residues. We have assayed HeLa nuclear extracts for the activity that catalyzes the poly(A) addition reaction. The authenticity of the in vitro assay was indicated by the observation that the poly(A) tract added in vitro is approximately 200 nucleotides in length. We have fractionated nuclear extracts in order to define components involved in specific poly(A) addition. No single fraction from DEAE-Sephacel chromatography of a HeLa nuclear extract possessed the specific poly(A) addition activity. However, if the various fractions were recombined, activity was restored, indicating the presence of multiple components. Further fractionation revealed the presence of at least two factors necessary for the poly(A) addition reaction. The reconstituted system retains the characteristics and specificity seen in the crude extract. Additional purification of one of the factors strongly suggests it to be a previously characterized poly(A) polymerase which, when assayed in the absence of the other factor, can add AMP to an RNA terminus but without specificity. Thus, the other component of the reaction may provide specificity to the process. In contrast to the 3' cleavage reaction, the poly(A) addition machinery does not possess an essential RNA component, as assayed by micrococcal nuclease digestion, nor do anti-Sm sera inhibit the reaction. Thus, the total process of formation of a polyadenylated mRNA 3' end is complex and requires the concerted action of distinct nuclear components.
细胞核中前体mRNA的聚腺苷酸化涉及特定的核酸内切酶切割,随后添加约200个腺苷酸残基。我们检测了HeLa细胞核提取物中催化聚腺苷酸添加反应的活性。体外检测的真实性通过以下观察得以证明:体外添加的聚腺苷酸尾长度约为200个核苷酸。我们对细胞核提取物进行了分级分离,以确定参与特定聚腺苷酸添加的成分。HeLa细胞核提取物经DEAE-葡聚糖凝胶色谱分离得到的单一馏分均不具有特定的聚腺苷酸添加活性。然而,如果将各种馏分重新组合,活性得以恢复,这表明存在多种成分。进一步的分级分离揭示了聚腺苷酸添加反应至少需要两种因子。重组系统保留了粗提取物中所见的特性和特异性。对其中一种因子的进一步纯化强烈表明它是一种先前已鉴定的聚腺苷酸聚合酶,在没有另一种因子的情况下进行检测时,它可以将AMP添加到RNA末端,但没有特异性。因此,反应的另一种成分可能为该过程提供特异性。与3'切割反应不同,经微球菌核酸酶消化检测,聚腺苷酸添加机制不具有必需的RNA成分,抗Sm血清也不抑制该反应。因此,聚腺苷酸化mRNA 3'末端形成的整个过程很复杂,需要不同细胞核成分的协同作用。